Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress
- PMID: 21087971
- DOI: 10.1167/iovs.10-6304
Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress
Abstract
Purpose: 5-HT(1A) agonists are neuroprotective in CNS injury models. The authors evaluated the efficacy of 5-HT(1A) agonists to protect the retina from severe blue light-induced photo-oxidative damage.
Methods: Albino rats were dosed (subcutaneously) with AL-8309A, 8-OH DPAT, or buspirone once or three times before 6-hour exposure to blue light. Electroretinograms (ERGs) were measured to assess retinal function, and retinal damage was evaluated by light microscopy. Topical ocular dosing with 1.75% AL-8309B was also evaluated. Rats were dosed with WAY-100635, a 5-HT(1A) antagonist, to determine whether protection required activation of the 5-HT(1A) receptor.
Results: ERG response amplitudes were significantly (P < 0.05) depressed more than 66% in vehicle-dosed rats after light exposure. ERGs were significantly higher in rats treated with AL-8309A (0.1-30 mg/kg), 8-OH DPAT (0.1-1 mg/kg), buspirone (5-20 mg/kg) or topical ocular with 1.75% AL-8309B. Retinas from AL-8309A and 8-OH DPAT-treated rats were devoid of histologic lesions. Significant protection was measured in rats dosed once 0, 24, or 48 hours before light exposure. Protection provided by dosing with AL-8309B or 8-OH DPAT was inhibited in rats predosed with WAY-100635.
Conclusions: 5-HT(1A) agonists provided potent and complete functional and structural protection. Protection was inhibited by treatment with WAY-100635, confirming the requirement for activating the 5-HT(1A) receptor in initiating this survival pathway. Single-dose experiments with AL-8309A suggest that the mechanism of protection is rapidly activated and protection persists for 48 hours. AL-8309B (1.75%) was effective after topical ocular dosing. AL-8309B is under evaluation in the clinic and may be useful in treating age-related macular degeneration.
Similar articles
-
Complement deposition and microglial activation in the outer retina in light-induced retinopathy: inhibition by a 5-HT1A agonist.Invest Ophthalmol Vis Sci. 2011 Oct 11;52(11):8108-16. doi: 10.1167/iovs.10-6418. Invest Ophthalmol Vis Sci. 2011. PMID: 21467172
-
The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.Anesth Analg. 2009 Apr;108(4):1169-76. doi: 10.1213/ane.0b013e318198f828. Anesth Analg. 2009. PMID: 19299781
-
Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy.Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4560-9. doi: 10.1167/iovs.15-16378. Invest Ophthalmol Vis Sci. 2015. PMID: 26200496 Free PMC article.
-
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. doi: 10.1016/j.ejphar.2005.09.065. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16310183 Review.
-
5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.Brain Res. 2016 Jun 1;1640(Pt A):5-14. doi: 10.1016/j.brainres.2015.11.026. Epub 2015 Nov 21. Brain Res. 2016. PMID: 26612522 Free PMC article. Review.
Cited by
-
Buspirone Enhances Cell Survival and Preserves Structural Integrity during Oxidative Injury to the Retinal Pigment Epithelium.Antioxidants (Basel). 2023 Dec 17;12(12):2129. doi: 10.3390/antiox12122129. Antioxidants (Basel). 2023. PMID: 38136248 Free PMC article.
-
The Role of Gut Microbiota in Glaucoma Progression and Other Retinal Diseases.Am J Pathol. 2023 Nov;193(11):1662-1668. doi: 10.1016/j.ajpath.2023.06.015. Epub 2023 Jul 23. Am J Pathol. 2023. PMID: 37490970 Review.
-
Repurposing Drugs for Treatment of Age-Related Macular Degeneration.Adv Exp Med Biol. 2023;1415:73-77. doi: 10.1007/978-3-031-27681-1_12. Adv Exp Med Biol. 2023. PMID: 37440017
-
Fluoxetine Protects Retinal Ischemic Damage in Mice.Pharmaceutics. 2023 Apr 29;15(5):1370. doi: 10.3390/pharmaceutics15051370. Pharmaceutics. 2023. PMID: 37242611 Free PMC article.
-
Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision.J Transl Med. 2022 Dec 7;20(1):572. doi: 10.1186/s12967-022-03738-4. J Transl Med. 2022. PMID: 36476500 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources